Recruiting OBSERVATIONAL NCT04146376

Von Willebrand Factor in Pregnancy (VIP) Study (VIP)

Von Willebrand Factor in Pregnancy (VIP) Study: A Multicenter Study of Wilate Use in Von Willebrand Disease for Childbirth

Sponsor: Ergomed

Conditions Von Willebrand Diseases

Interventions Tranexamic acid Use of a postpartum diary and additional blood draws Use of a postpartum diary and additional blood draws. VWF replacement therapy with Wilate

Updated 13 times since 2019 Last updated: Dec 10, 2025 Started: Oct 12, 2019 Primary completion: Dec 31, 2026 Completion: Dec 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Von Willebrand Diseases, this trial is actively recruiting participants. The trial is conducted by Ergomed and has accumulated 13 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

13 versions recorded

Jan 2026 — Present [monthly]

Recruiting
Sep 2025 — Jan 2026 [monthly]

Recruiting
Feb 2025 — Sep 2025 [monthly]

Recruiting
Oct 2024 — Feb 2025 [monthly]

Recruiting

Status: Unknown → Recruiting
Sep 2024 — Oct 2024 [monthly]

Unknown

▶ Show 8 earlier versions

Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jul 2023 — Jul 2024 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Dec 2021 — Jul 2023 [monthly]

Recruiting
Feb 2021 — Dec 2021 [monthly]

Recruiting
Jan 2021 — Feb 2021 [monthly]

Recruiting
Nov 2020 — Jan 2021 [monthly]

Recruiting
Jun 2020 — Nov 2020 [monthly]

Recruiting

Status: Active Not Recruiting → Recruiting
Nov 2019 — Jun 2020 [monthly]

Active Not Recruiting

First recorded

Oct 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ergomed
Octapharma
University of Washington

Data source: University of Washington

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Atlanta, United States , Aurora, United States , Hershey, United States , Miami, United States , Nashville, United States , New Haven, United States , New Orleans, United States , Peoria, United States , Portland, United States , Salt Lake City, United States and 1 more location